Chicago Equity Partners’s Corcept Therapeutics CORT Stock Holding History

Chicago Equity Partners’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-34,145	Closed	-$413K	–	696
2019 Q4	$413K	Sell	34,145 -37,710	-52%	-$525K	0.02%	680
2019 Q3	$1.02M	Buy	71,855 +55,710	+345%	+$685K	0.05%	492
2019 Q2	$180K	Buy	+16,145	New	+$180K	0.01%	863
2018 Q1	–	Sell	-123,010	Closed	-$2.22M	–	763
2017 Q4	$2.22M	Sell	123,010 -13,770	-10%	-$249K	0.07%	346
2017 Q3	$2.64M	Buy	136,780 +61,615	+82%	+$919K	0.08%	312
2017 Q2	$887K	Buy	75,165 +20,730	+38%	+$225K	0.02%	527
2017 Q1	$597K	Buy	54,435 +2,680	+5%	+$23.5K	0.02%	558
2016 Q4	$376K	Sell	51,755 -10,540	-17%	-$82.6K	0.01%	639
2016 Q3	$405K	Buy	+62,295	New	+$362K	0.01%	597

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Chicago Equity Partners's CORT Position: Q1 2020 in Review

Chicago Equity Partners sold out of Corcept Therapeutics (CORT) in Q1 2020, closing a stake of 34,145 shares — an estimated $413K sold.

Chicago Equity Partners first reported a position in CORT in Q3 2016 and held it in 9 quarters. The position peaked at $2.64M in Q3 2017. 204 funds tracked by Wall St. Rank hold CORT as of Q1 2020.

Chicago Equity Partners reported no remaining Corcept Therapeutics position as of Q1 2020 after selling out during the quarter.
Chicago Equity Partners sold 34,145 Corcept Therapeutics shares in Q1 2020, an estimated $413K.
Chicago Equity Partners first reported a position in Corcept Therapeutics in Q3 2016 and held it in 9 quarters.
Chicago Equity Partners's Corcept Therapeutics position peaked at $2.64M in Q3 2017.
204 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.